banda transcan

TRANSCAN Partners

The ERA-Net TRANSCAN was made up of 25 partners from 19 European and Associated countries. TRANSCAN reached good geographic coverage throughout the European Union, and also included three Associated countries (Israel, Norway and Turkey).

Most of the participating organisations represent dedicated funding bodies (ministries, research councils, etc). Other organisations are mandated by a national research council or a health ministry to represent their country in TRANSCAN, but in addition play an active role in cancer research.

All TRANSCAN partners have participated in the elaboration of the work programme and taken responsibilities well-suited to their expertise.

LIST of PARTNERS:
- Austrian Science Fund (FWF), Austria
- Research Foundation Flanders (FWO), Belgium*
- Masaryk Memorial Cancer Institute (MMCI), Czech Republic
- National Cancer Institute (INCa), France
- Federal Ministry of Education and Research (BMBF), Germany
- Project Management Agency in the German Aerospace Centre (DLR), Germany
- General Secretariat for Research and Technology, Ministry of Education, Life Long Learning and Religious Affairs (GSRT), Greece
- Hellenic Centre for Disease Control & Prevention (KEELPNO), Greece
- National Institute of Oncology (NIO), Hungary
- Chief Scientist Office of the Ministry of Health (CSO-MOH), Israel
- Ministry of Health (MoH), Italy
- National Institute of Health (ISS), Italy
- Alliance Against Cancer (ACC), Italy
- Liguria Region, (LR), Italy
- Ministry of Education, University and Research, (MIUR), Italy
- Latvian Academy of Science (LAS), Latvia
- The Netherlands Organisation for Health Research and Development (ZoN-MW), Netherlands
- The Research Council of Norway (RCN), Norway
- National Centre for Research and Development (NCBiR), Poland
- Foundation for Science and Technology (FCT), Portugal
- Institute of Oncology (IOB), Romania
- Slovak Academy of Sciences (SAS), Slovakia
- Ministry of Higher Education, Science and Technology (MHEST), Slovenia
- Institute of Health Carlos III (ISCIII), Spain
- Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey    
- Cancer Research UK (CR-UK), United Kingdom

*The Research Foundation – Flanders (FWO) acted as an associated partner in TRANSCAN.

Successively the European Commission approved the enlargement of the network with the accession of three new partners, namely the following charities (the approval is dated October 1st, 2014, the accession went into effect retroactively beginning on 12 September 2012):

- ARC French Foundation for Cancer Research (ARC), France
- Norwegian Cancer Society (NCS), Norway
- Dutch Cancer Society (DCS), Netherlands

 

 

 


TRANSCAN-2 News


Fourth Joint Transnational Call 2017 (JTC 2017)

on: Translational Research on Rare Cancers

12 projects selected for funding

visit the page

Newsletters

Newsletter 7, October 2018

Newsletter 6, June 2108
Newsletter 5, March 2018
Newsletter 4, December 2017
Newsletter 3, September 2017
Newsletter 2, April 2017
Newsletter 1, December 2016

To subscribe to TRANSCAN-2 newsletter mailing list please send an email to: This email address is being protected from spambots. You need JavaScript enabled to view it.

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.